iBio, Inc.: cash_and_equivalents
| Value | {"amount": 28672000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2025-12-31) |
| Status | current |
| Entity | iBio, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:56:17.638186+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9c17dd6e-f5e0-42d7-a8a4-b492922d7257
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001420720-26-000004Retrieved: 2026-08-19T13:56:17.638186+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001420720/cash-and-equivalents/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9c17dd6e-f5e0-42d7-a8a4-b492922d7257
History
- no predecessors — first report